Early Lapatinib-Induced Skin Rash Predicts Better Survival With Lapatinib+Trastuzumab Therapy - Cancer Therapy Advisor

Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.

Lapatinib and lapatinib plus trastuzumab therapy versus

A phase 1 study evaluating the combination of an allosteric AKT

Therapeutic vaccines for breast cancer: Has the time finally come

PDF) Risk-based decision-making in the treatment of HER2-positive

Biomedicines, Free Full-Text

Association between efficacy and skin rash following treatment

Molecules, Free Full-Text

Neoadjuvant Therapy in HER2-Positive Breast Cancer: Ready for

Targeted drug delivery strategies for precision medicines

PDF) A phase II study of afatinib (BIBW 2992), an irreversible